THE GOAL OF BASIS NEURO PLATFORM IS TO MAKE NEURO TECHNOLOGIES AVAILABLE TO ANY BUSINESS AND INDUSTRIES AND TO PROVIDE THE MASS MARKET WITH NEURO PRODUCTS AND SERVICES
Access to services, technologies and information support to develop products with neurointerfaces.
Application and integration of neural interfaces into currently used products or services.
New product development with hardware, algorithms and a pattern database from Basis Neuro.
Integration of neural interfaces into technologies created by external developers.
Development of a BCI product "from idea to launch" with the support of Basis Neuro specialists.
Access to resources and a team of competitive specialists.
Technical support to the platform users.
Promotion of neurotechnologies to capture the audience.
Patent: Vladimirsky B.M., Vladimirsky B.B., Kan M.N., Shepelev I.E. A method for classification of electroencephalographic signals in the brain-computer interface. Patent for invention № 2415642, 10.04.2011.
2017
2018
2019
2020
2021
2022
Verified 67%
Attention. There is a risk that unverified members are not actually members of the team
Verified 0%
Attention. There is a risk that unverified members are not actually members of the team
Summary
Basis Neuro is bringing the world into the next age of technology; an age where computers and the human mind can interact. This is the cutting-edge of technology, and its uses are virtually limitless and span from simple entertainment to aiding in advanced medical procedures. This is an exciting new ICO, and with working prototypes, they are definitely a head-turner. Keep your eye on Basis Neuro over the course of the next year.
Positives
Basis neuro has already developed several working prototypes
Application of brain-computer interfaces is limitless
The technology is cutting-edge and incredibly popular since the advent of VR
Negatives
At first, the technology could be very expensive
Most major countries who have money to invest are barred from the ICO
Strengths: extensive market research with forecasts, stats and main players overview. Vast practical experience of team members in the field of neural interfaces (since 2007). A detailed, yet comprehensible explanation of neural technologies functionality and applicability. Deloitte as project’s partner (legal and tax support). The WP has all important components, including financial projections, market research and competitor analysis.
Weaknesses: the technology behind this project is very advanced, it may require additional funds, according to analysts from expert-coin rating. There is no marketing plan. There are just 3 advisors and no experts in ICO, cryptocurrency.
The potential of BCIs to become a ubiquitous and widely adopted technology still has a long way to go, but that has not stopped Basis Neuro from incorporating blockchain technology into the innovations. While it is exciting to get to control things with your mind, the ultimate challenge comes in the gradual adoption of BCI technology.
This offer is based solely on information provided by the offeror and other publicly available sources.
The token sale or exchange event is completely independent of ICOholder. ICOholder is not involved in any way, including technical support or promotion.
We list token sales from entities with which we have no relationship to help users track overall activity within the token sector. This information is not intended as advice, and you should seek professional or specialist guidance or conduct your own due diligence before making any decisions based on our content.
Any terms and conditions regarding token acquisition are solely between contributors and the token issuer. ICOholder is not the seller of these tokens.
ICOholder is not legally responsible for any representations made by third parties about any token sale. Any claims for breach of contract must be directed against the listed token issuing entity.
If you have concerns about the nature, legality, or propriety of a token sale or the involved individuals, please contact info@icoholder.com with detailed information.